Forest Laboratories agreed to a $38 million settlement without admitting any liability to resolve allegations of paying kickbacks to physicians. The whistleblower lawsuit accused the company of making payments disguised as speaking fees, sometimes without speaking engagements or licensed health care providers in attendance, in return for prescribing Bystolic, Savella and Namenda.